Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Dermatomyositis”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT05192200
What this trial is testing

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Who this might be right for
Dermatomyositis
Pfizer 24
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Not applicableNot Yet RecruitingNCT06599411
What this trial is testing

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Who this might be right for
Atopic DermatitisPsoriasisHidradenitis Suppurativa+7 more
Assistance Publique - Hôpitaux de Paris 700
Early research (Phase 1)Looking for participantsNCT06647069
What this trial is testing

DR-0201 in Subjects With Autoimmune Diseases

Who this might be right for
SLESLE (Systemic Lupus)CLE+9 more
Dren Bio 36
Not applicableUnknownNCT03324152
What this trial is testing

Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Karolinska University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02029274
What this trial is testing

Safety and Efficacy of BAF312 in Dermatomyositis

Who this might be right for
Active Dermatomyositis
Novartis Pharmaceuticals 17
Not applicableStudy completedNCT00866125
What this trial is testing

Hand Function in Patients With Poly- or Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Karolinska Institutet 31
Large-scale testing (Phase 3)Looking for participantsNCT05895786
What this trial is testing

Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Who this might be right for
Myositis
Pfizer 318
Large-scale testing (Phase 3)Ended earlyNCT03981744
What this trial is testing

Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments

Who this might be right for
PolymyositisDermatomyositis
Janssen Pharmaceutical K.K. 51
Large-scale testing (Phase 3)Looking for participantsNCT06154252
What this trial is testing

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more
Cabaletta Bio 74
Testing effectiveness (Phase 2)Study completedNCT01415219
What this trial is testing

Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis

Who this might be right for
DermatomyositisPolymyositis
University Hospital, Lille 80
Not applicableStudy completedNCT01813617
What this trial is testing

Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Karolinska University Hospital 72
Large-scale testing (Phase 3)Study completedNCT02971683
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
PolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more
Bristol-Myers Squibb 149
Large-scale testing (Phase 3)Enrolling By InvitationNCT05495321
What this trial is testing

Interleukin-2 on Active Dermatomyositis

Who this might be right for
Dermatomyositis
Peking University People's Hospital 240
Not applicableNot Yet RecruitingNCT06460766
What this trial is testing

Validity and Reliability of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Questionnaire

Who this might be right for
Rheumatic DiseasesPediatric ALLChildren, Only
Istanbul University - Cerrahpasa 70
Not applicableUnknownNCT05027152
What this trial is testing

Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisPolymyositis
Federal University of Espirito Santo 30
Testing effectiveness (Phase 2)Study completedNCT04628936
What this trial is testing

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04033926
What this trial is testing

KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 25
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240
Early research (Phase 1)UnknownNCT05986162
What this trial is testing

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Biotech Pharmaceutical Co., Ltd. 44
Load More Results